ADJUVANT REGORAFENIB IN STAGE IV COLORECTAL CANCER (CRC) AFTER CURATIVE TREATMENT OF LIVER METASTASES: A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY (COAST)

被引：0
|
作者：
Eric, Van Cutsem [1 ]
Takayuki, Yoshino [2 ]
Xu Rui-Hua [3 ]
John, Zalcberg [4 ]
Daniel, Sargent [5 ,6 ]
Michael, Choti [7 ]
Mark, Rutstein [8 ]
Lisa, Cupit [8 ]
Iris, Kuss [9 ]
Axel, Grothey [10 ]
机构：
[1] UZ Leuven, Leuven Canc Inst, Leuven, Belgium
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Mayo Clin, Rochester, MN USA
[6] Mayo Canc Ctr, Rochester, MN USA
[7] UT Southwestern Med Ctr, Dallas, TX USA
[8] Bayer Healthcare, Whippany, NJ USA
[9] Bayer Pharma AG, Berlin, Germany
[10] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu165.261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 0266
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [31] BP-C1 in treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and additional open-label treatment phase
    Larsen, Stig Einride
    Manikhas, Alexey
    Trishkina, Ekaterina
    Matrosova, Marina
    Poddubuskaya, Elena
    Jensen, Steen Lindkaer
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter, randomized,double-blinded,placebo-controlled,phase Ⅱclinical trial
    RuiHua Xu
    Lin Shen
    KeMing Wang
    Gang Wu
    ChunMei Shi
    KeFeng Ding
    LiZhu Lin
    JinWan Wang
    JianPing Xiong
    ChangPing Wu
    Jin Li
    YunPeng Liu
    Dong Wang
    Yi Ba
    JuePing Feng
    YuXian Bai
    JingWang Bi
    LiWen Ma
    Jian Lei
    Qing Yang
    Hao Yu
    Chinese Journal of Cancer, 2017, 36 (12) : 677 - 685
  • [33] Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study
    Lipton, Richard B.
    Buse, Dawn C.
    Sandoe, Claire H.
    Ford, Janet H.
    Hand, Austin L.
    Jedynak, Jakub P.
    Port, Martha D.
    Detke, Holland C.
    HEADACHE, 2023, 63 (05): : 683 - 691
  • [34] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
    Gronberg, Bjorn H.
    Ciuleanu, Tudor
    Flotten, Oystein
    Knuuttila, Aija
    Abel, Edvard
    Langer, Seppo W.
    Krejcy, Kurt
    Liepa, Astra M.
    Munoz, Maria
    Hahka-Kemppinen, Marjo
    Sundstrom, Stein
    LUNG CANCER, 2012, 78 (01) : 63 - 69
  • [36] Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
    Sheraz Yaqub
    Bjørn Atle Bjørnbeth
    Jon-Helge Angelsen
    Claus Wilki Fristrup
    Jon Erik Grønbech
    Oskar Hemmingsson
    Bengt Isaksson
    Ingebjørg Soterud Juel
    Peter Nørgaard Larsen
    Gert Lindell
    Frank Viborg Mortensen
    Kim Erlend Mortensen
    Magnus Rizell
    Per Sandström
    Oddvar Mathias Sandvik
    Ernesto Sparrelid
    Helena Taflin
    Kjetil Taskén
    Trials, 22
  • [37] Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
    Yaqub, Sheraz
    Bjornbeth, Bjorn Atle
    Angelsen, Jon-Helge
    Fristrup, Claus Wilki
    Gronbech, Jon Erik
    Hemmingsson, Oskar
    Isaksson, Bengt
    Juel, Ingebjorg Soterud
    Larsen, Peter Norgaard
    Lindell, Gert
    Mortensen, Frank Viborg
    Mortensen, Kim Erlend
    Rizell, Magnus
    Sandstrom, Per
    Sandvik, Oddvar Mathias
    Sparrelid, Ernesto
    Taflin, Helena
    Tasken, Kjetil
    TRIALS, 2021, 22 (01)
  • [38] Parenteral troxerutin and carbazochrome combination in the treatment of posthemorrhoidectomy status: A randomized, double-blind, placebo-controlled, phase IV study
    Basile, M
    Gidaro, S
    Pacella, M
    Biffignandi, PM
    Gidaro, GS
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (04) : 256 - 261
  • [39] LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
    Schimanski, Carl Christoph
    Moehler, Markus
    Schoen, Michael
    van Cutsem, Eric
    Greil, Richard
    Bechstein, Wolf Otto
    Hegewisch-Becker, Susanna
    von Wichert, Goetz
    Voehringer, Matthias
    Heike, Michael
    Heinemann, Volker
    Peeters, Marc
    Kanzler, Stephan
    Kasper, Stefan
    Overkamp, Friedrich
    Schroeder, Jan
    Seehofer, Daniel
    Kullmann, Frank
    Linz, Bernhard
    Schmidtmann, Irene
    Smith-Machnow, Victoria
    Gockel, Ines
    Lang, Hauke
    Galle, Peter R.
    BMC CANCER, 2012, 12
  • [40] INTRAVENOUS CLODRONATE FOR THE TREATMENT OF HYPERCALCEMIA IN BREAST-CANCER PATIENTS WITH BONE METASTASES - A PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED MULTICENTER STUDY
    ROTSTEIN, S
    GLAS, U
    ERIKSSON, M
    PFEIFFER, P
    HANSEN, J
    SODERQVIST, J
    BANDMANN, U
    STRID, S
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 890 - 893
12345